+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Protection Against Chlamydia trachomatis Infection and Upper Genital Tract Pathological Changes by Vaccine-Promoted Neutralizing Antibodies Directed to the VD4 of the Major Outer Membrane Protein



Protection Against Chlamydia trachomatis Infection and Upper Genital Tract Pathological Changes by Vaccine-Promoted Neutralizing Antibodies Directed to the VD4 of the Major Outer Membrane Protein



Journal of Infectious Diseases 212(6): 978-989



The VD4 region from the Chlamydia trachomatis major outer membrane protein contains important neutralizing B-cell epitopes of relevance for antibody-mediated protection against genital tract infection. We developed a multivalent vaccine construct based on VD4s and their surrounding constant segments from serovars D, E, and F. Adjuvanted with cationic liposomes, this construct promoted strong immune responses to serovar-specific epitopes, the conserved LNPTIAG epitope and neutralized serovars D, E, and F. Vaccinated mice were protected against challenge, with protection defined as reduced bacterial numbers in vagina and prevention of pathological changes in the upper genital tract. Adoptive transfer of serum and T-cell depletion experiments demonstrated a dominant role for antibodies and CD4(+) T cells in the protective immune response. Integrating a multivalent VD4 construct into the sequence of the major outer membrane protein resulted in a protective and broadly neutralizing vaccine. Our findings emphasize the important role of antibodies in protection against Chlamydia trachomatis.

(PDF emailed within 0-6 h: $19.90)

Accession: 058648270

Download citation: RISBibTeXText

PMID: 25748320

DOI: 10.1093/infdis/jiv137


Related references

Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infection and Immunity 63(12): 4704-4714, 1995

Major outer membrane protein variants of Chlamydia trachomatis are associated with severe upper genital tract infections and histopathology in San Francisco. Journal of Infectious Diseases 172(4): 1013-1022, 1995

Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: Serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection. Vaccine 13(11): 1023-1032, 1995

Protective immunity against Chlamydia trachomatis genital infection induced by a vaccine based on the major outer membrane multi-epitope human papillomavirus major capsid protein L1. Vaccine 29(15): 2672-2678, 2011

Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes. Infection and Immunity 68(12): 6798-6806, 2000

Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge. Vaccine 21(13-14): 1455-1465, 2003

Poliovirus hybrids expressing neutralization epitopes from variable domains I and IV of the major outer membrane protein of Chlamydia trachomatis elicit broadly cross-reactive C. trachomatis-neutralizing antibodies. Infection and Immunity 63(3): 1116-1121, 1995

Mimicry of a neutralizing epitope of the major outer membrane protein of Chlamydia trachomatis by anti-idiotypic antibodies. Infection and Immunity 62(2): 341-347, 1994

Characterization of a neutralizing monoclonal antibody directed at variable domain I of the major outer membrane protein of Chlamydia trachomatis C-complex serovars. Infection and Immunity 61(4): 1365-1370, 1993

Characterization of a c and c related complex neutralizing monoclonal antibody directed at the vd i region of the major outer membrane protein momp of chlamydia trachomatis. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 32: 251, 1992

Mapping of neutralizing epitopes of the major outer membrane protein from Chlamydia trachomatis serovar K by use of antibodies and synthetic peptides. Journal of Immunology 150(8 PART 2): 235A, 1993

Polymorphism in the major outer membrane protein of Chlamydia trachomatis is associated with severe genital tract infections in San Francisco. Abstracts of the General Meeting of the American Society for Microbiology 95(0): 276, 1995

Major outer membrane protein polymorphism of Chlamydia trachomatis is associated with severity of genital tract infections in San Francisco. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 35(0): 303, 1995

Heterotypic protection of mice against chlamydial salpingitis and colonization of the lower genital tract with a human serovar F isolate of Chlamydia trachomatis by prior immunization with recombinant serovar L1 major outer-membrane protein. Journal of General Microbiology 138 Pt 8: 1707-1715, 1992

Functional and structural mapping of Chlamydia trachomatis species-specific major outer membrane protein epitopes by use of neutralizing monoclonal antibodies. Infection and Immunity 59(11): 4147-4153, 1991